Sector : Pharmaceuticals & Drugs
BSE
480.50 -0.38%
NSE
480.70 -0.33 %
Mar 22, 13:23
Mar 22, 09:36
Zydus Lifesciences shares gain following USFDA approval for Tofacitinib tablets
Mar 08, 10:01
Zydus Lifesciences gets final USFDA approval for cancer drug; shares flat
Mar 08, 09:58
Zydus Lifesciences gets final USFDA approval for cancer drug; shares flat
Mar 22, 13:17
Mar 24, 16:01
Price
BSE
480.50 -0.38%
NSE
480.70 -0.33%
Share Target
Target(Rs)
Tip Period
Stop Loss
Your permanent Nickname can be distinct from your username and no one need know the link between the two.